Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

512
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Polygenic Traits01:18

Polygenic Traits

66.5K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Multi-omic modelling of body mass index response to a dietary weight loss intervention.

Gut microbes·2026
Same author

Genetic Determinants of Pulmonary Artery Size in over 50,000 Subjects with and without COPD.

medRxiv : the preprint server for health sciences·2026
Same author

Multi-ancestry modeling improves fine-mapping resolution, protein prediction, and discovery for proteome-wide association studies.

medRxiv : the preprint server for health sciences·2026
Same author

Genetic and transcriptomic determinants of disseminated coccidioidomycosis identify a founder variant in <i>NLRX1</i> and ancestry-specific rare variants in immune response genes.

medRxiv : the preprint server for health sciences·2026
Same author

Genetic drivers of etiologic heterogeneity in thyroid cancer.

Nature communications·2026
Same author

A blended genome and exome sequencing method captures genetic variation in an unbiased and cost-effective manner.

Nature genetics·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

540

Las puntuaciones poligénicas de múltiples tratos para la EPOC y las exacerbaciones de la EPOC implican proteínas

Chengyue Zhang, Iain R Konigsberg, Yixuan He

    medRxiv : the preprint server for health sciences
    |September 5, 2025
    PubMed
    Resumen

    El desarrollo de puntuaciones poligénicas de múltiples rasgos (PRS) mejora la predicción de la enfermedad pulmonar obstructiva crónica (EPOC) e identifica posibles objetivos farmacológicos. Este enfoque mejora la evaluación del riesgo para la EPOC y las exacerbaciones.

    Más Videos Relacionados

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
    05:53

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

    Published on: June 21, 2018

    10.2K
    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    1.5K

    Videos de Experimentos Relacionados

    Last Updated: Sep 9, 2025

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    540
    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
    05:53

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

    Published on: June 21, 2018

    10.2K
    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    1.5K

    Área de la Ciencia:

    • Genética y genómica
    • Medicina de los pulmones
    • Medicina de precisión

    Sus antecedentes:

    • La enfermedad pulmonar obstructiva crónica (EPOC) representa una carga significativa para la salud mundial.
    • La predicción precisa del riesgo y las exacerbaciones de la EPOC es crucial para una gestión eficaz.
    • Los modelos predictivos actuales pueden no capturar completamente los complejos fundamentos genéticos y biológicos de la EPOC.

    Objetivo del estudio:

    • Desarrollar y validar las puntuaciones poligénicas de múltiples rasgos (PRS) para predecir la EPOC y las exacerbaciones.
    • Identificar las proteínas asociadas a la PRS para su potencial tratamiento dirigido en la EPOC.
    • Evaluar el rendimiento de los PRS con múltiples características en comparación con los PRS con un solo rasgo.

    Principales métodos:

    • Utilizó PRSmix+, un marco de PRS de múltiples rasgos, que incorpora 7 rasgos en un PRS compuesto (PRSmulti).
    • PRS multi validado en diversas cohortes prospectivas que incluyen COPDGene, ECLIPSE, Todos nosotros y Biobanco del Reino Unido.
    • PRS integrado con datos proteómicos para identificar y validar las proteínas relacionadas con el PRS, vinculándolas a fármacos existentes o en investigación.

    Principales resultados:

    • El PRS compuesto (PRSmulti) demostró asociaciones significativas con el estado de la EPOC y la frecuencia de la exacerbación en todas las cohortes.
    • PRSmulti superó al PRS tradicional de un solo rasgo en precisión predictiva.
    • Se identificaron 73 proteínas asociadas a PRS, con 25 vinculadas a objetivos farmacológicos, incluidos AGER, IL1RL1 y SCARF2.

    Conclusiones:

    • El PRS de múltiples rasgos ofrece una mejor predicción de la EPOC y el riesgo de exacerbación.
    • La integración de PRS con datos proteómicos identifica con éxito nuevos objetivos terapéuticos farmacológicos.
    • Este enfoque representa una estrategia prometedora para el avance de la medicina de precisión en el tratamiento de la EPOC.